CD8A and melanoma: TEXscore presented non-inferior predictive capacity for ICB in melanoma (GSE91061 and GSE78220) compared with CD8 + T effector and T cell inflamed gene expression profile (GEP), which commonly associated with immune activation (Additional file 4: Figure S4A–D).